Pyrexar Medical is the pioneer and worldwide market leader in development and manufacture of innovative and highly effective cancer fighting products
Hypertherima is used in the treatment of most soft tissue cancers. By heating cancer tumors to 42 degrees Celsius (108F) the body increases oxygen and blood flow to the cancer site, improving Chemotherapy and Radiotherapy. Heating also inhibits DNA repair so cells damaged by radiation do not recover. Hyperthermia can directly kill cancer cells and shrink tumors on its own, but is generally accepte
d as an adjunct therapy. The process also has immunological effects by creating heat shock proteins essential for the bodies immune system to identify cancer cells.
Be the first to know and let us send you an email when Pyrexar Medical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
